19 August 2019
MTPConnect is excited to announce the appointment of Andrew Bowskill to the team, in the role of Director of Stakeholder Engagement for Queensland.
12 August 2019
MTPConnect is excited to announce the appointment of Dr Kate Brooks to the team, in the role of Director of Stakeholder Engagement for Western Australia.
02 August 2019
Check out all the activities from the MTPConnect staff in July!
19 July 2019
The new Biomedical Translation Bridge (BTB) funding program is attracting strong interest from Australian life science innovators.
09 July 2019
MTPConnect encourages you to join the Australian delegation to the 2019 MedTech Conference in Boston. To help you get the most out of your visit, we’re developing an exciting suite of value-added activities in and around Boston which you can only access as part of the MTPConnect-led delegation and which you can see on our dedicated page.
28 June 2019
Check out what the MTPConnect team has been up to this month.
26 June 2019
Certara Announces First Recipients of Certara-Monash University Industry Drug Development Fellowships
Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, and Monash University today announced the recipients of the inaugural Certara-Monash University Industry Drug Development Fellowships – Dr. Katrina Hui, Dr. Yu-Wei Lin, and Dr. Zheng Liu.
25 June 2019
By: Dr Dan Grant
21 June 2019
Emerging leaders in the medtech, biotech or pharmaceutical sector are being offered the chance to gain board-level experience through a unique new program offered by MTPConnect.
11 June 2019
Coming off of a stellar week at BIO International Convention, our focus now shifts to another must-attend MedTech Conference in Boston.
10 June 2019
Article by Tamra Sami, published in BioWorld on 7 June 2019.
06 June 2019
A new report released by MTPConnect at the BIO international convention in Philadelphia highlights the role played by multinational pharmaceutical and medical technology companies in nurturing Australia’s healthtech research and commercialisation.
04 June 2019
Clarivate Analytics signs agreement with Melbourne Biomedical Precinct to provide comprehensive drug discovery intelligence
Clarivate Analytics, a global leader in providing trusted insights and analytics to accelerate the pace of innovation, has signed an agreement to provide drug discovery intelligence across the Melbourne Biomedical Precinct (MBP).